FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging: Version 1.0

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 37, Issue 1, 2010, Pages 181-200

  Boellaard, Ronald ^a   O'Doherty, Mike J ^b   Weber, Wolfgang A ^c   Mottaghy, Felix M ^d   Lonsdale, Markus N ^e   Stroobants, Sigrid G ^f   Oyen, Wim J G ^g   Kotzerke, Joerg ^h   Hoekstra, Otto S ^a   Pruim, Jan ⁱ   Marsden, Paul K ^b   Tatsch, Klaus ^j   Hoekstra, Corneline J ^k   Visser, Eric P ^g   Arends, Bertjan ^l   Verzijlbergen, Fred J ^m   Zijlstra, Josee M ^a   Comans, Emile F I ^a   Lammertsma, Adriaan A ^a   Paans, Anne M ⁱ   Willemsen, Antoon T ⁱ   Beyer, Thomas ⁿ   Bockisch, Andreas ^o   Schaefer Prokop, Cornelia ^p   Delbeke, Dominique ^q   Baum, Richard P ^r   Chiti, Arturo ^s   Krause, Bernd J ^t   more..

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF FREIBURG   (Germany)

^d UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^e BISPEBJERG HOSPITAL   (Denmark)

^f ANTWERP UNIVERSITY HOSPITAL   (Belgium)

^g RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^h UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

ⁱ UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^j European Association of Nuclear Medicine   (Austria)

^k JEROEN BOSCH HOSPITAL   (Netherlands)

^l CATHARINA HOSPITAL   (Netherlands)

^m ST ANTONIUS HOSPITAL   (Netherlands)

ⁿ cmi experts GmbH   (Switzerland)

^o UNIVERSITY HOSPITAL ESSEN   (Germany)

^p ACADEMIC MEDICAL CENTER   (Netherlands)

^q VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^r Centre for PET/CT   (Germany)

^s HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^t TECHNICAL UNIVERSITY OF MUNICH   (Germany)

more..

Author keywords

FDG; Guideline; Oncology; PET; PET CT; QA; QC; Quantification; Tumour

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADVANCED CANCER; BREAST CANCER; CANCER DIAGNOSIS; COLORECTAL CANCER; COMPUTER ASSISTED TOMOGRAPHY; ESOPHAGUS CANCER; GASTROINTESTINAL STROMAL TUMOR; HEAD AND NECK CANCER; HUMAN; LUNG CANCER; LUNG NON SMALL CELL CANCER; LYMPHOMA; NONHODGKIN LYMPHOMA; PHYSICIAN; POSITRON EMISSION TOMOGRAPHY; PRACTICE GUIDELINE; QUALITY CONTROL; QUANTITATIVE DIAGNOSIS; REVIEW; UTERINE CERVIX CANCER;

EUROPE; FLUORODEOXYGLUCOSE F18; HUMANS; NEOPLASMS; NUCLEAR MEDICINE; POSITRON-EMISSION TOMOGRAPHY; PRACTICE GUIDELINES AS TOPIC; RADIOPHARMACEUTICALS; SUBTRACTION TECHNIQUE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 72949107608     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-009-1297-4     Document Type: Review

References (39)

1. D Delbeke RE Coleman MJ Guiberteau ML Brown HD Royal BA Siegel, et al. 2006 Procedure guideline for tumour imaging with 18F-FDG PET/CT 1.0 J Nucl Med. 47 885 895 16644760
2. BJ Krause T Beyer A Bockisch D Delbeke J Kotzerke V Minkov, et al. 2007 FDG-PET/CT in oncology. German guideline Nuklearmedizin. 46 291 301 1:STN:280:DC%2BD1c%2FmtFertQ%3D%3D 18084685
3. R Boellaard WJ Oyen CJ Hoekstra OS Hoekstra EP Visser AT Willemsen, et al. 2008 The Netherlands protocol for standardisation and quantification of FDG whole body PET studies in multi-centre trials Eur J Nucl Med Mol Imaging 35 2320 2333 10.1007/s00259-008-0874-2 18704407
4. P Bourguet MP Blanc-Vincent A Boneu L Bosquet B Chauffert C Corone, et al. 2003 Summary of the standards, options and recommendations for the use of positron emission tomography with 2-[18F]fluoro-2-deoxy-D-glucose (FDG-PET scanning) in oncology (2002) Br J Cancer. 89 Suppl 1 S84 91 10.1038/sj.bjc. 6601088 12915907 (Pubitemid 37076153)
5. RE Coleman D Delbeke MJ Guiberteau PS Conti HD Royal JC Weinreb, et al. 2005 Concurrent PET/CT with an integrated imaging system: Intersociety dialogue from the joint working group of the American College of Radiology, the Society of Nuclear Medicine, and the Society of Computed Body Tomography and Magnetic Resonance J Nucl Med. 46 1225 1239 16000293 (Pubitemid 43741086)
6. JW Fletcher B Djulbegovic HP Soares BA Siegel VJ Lowe GH Lyman, et al. 2008 Recommendations on the use of F-18-FDG PET in oncology J Nucl Med. 49 480 508 10.2967/jnumed.107.047787 18287273 (Pubitemid 351355215)
7. ME Juweid S Stroobants OS Hoekstra FM Mottaghy M Dietlein A Guermazi, et al. 2007 Use of positron emission tomography for response assessment of lymphoma: Consensus of the Imaging Subcommittee of International Harmonization Project in lymphoma J Clin Oncol. 25 571 578 10.1200/JCO.2006.08.2305 17242397 (Pubitemid 350002965)
8. AA Lammertsma CJ Hoekstra G Giaccone OS Hoekstra 2006 How should we analyse FDG PET studies for monitoring tumour response? Eur J Nucl Med Mol Imaging 33 Suppl 1 16 21 10.1007/s00259-006-0131-5 16763817
9. JC Miller AJ Fischman SL Aquino MA Blake JH Thrall SI Lee 2007 FDG-PET CT for tumour imaging J Am Coll Radiol. 4 256 259 10.1016/j.jacr.2006.10.011 17412280 (Pubitemid 46505118)
10. HR Schelbert CK Hoh HD Royal M Brown MN Dahlbom F Dehdashti, et al. 1998 Procedure guideline for tumour imaging using fluorine-18-FDG. Society of Nuclear Medicine J Nucl Med. 39 1302 1305 1:STN:280:DyaK1czjt1Skug%3D%3D 9669415
11. LK Shankar JM Hoffman S Bacharach MM Graham J Karp AA Lammertsma, et al. 2006 Consensus recommendations for the use of F-18-FDG PET as an indicator of therapeutic response in patients in National Cancer Institute trials J Nucl Med. 47 1059 1066 1:CAS:528:DC%2BD28XmtlWmt7s%3D 16741317
12. RL Wahl H Jacene Y Kasamon MA Lodge 2009 From RECIST to PERCIST: evolving considerations for PET response criteria in solid tumours J Nucl Med. 50 Suppl 1 122S 1250 10.2967/jnumed.108.057307 1:CAS:528:DC%2BD1MXmtFahtr8%3D 19403881
13. H Young R Baum U Cremerius K Herholz O Hoekstra AA Lammertsma, et al. 1999 Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendations. European Organization for Research and Treatment of Cancer (EORTC) PET Study Group Eur J Cancer. 35 1773 1782 10.1016/S0959-8049(99)00229-4 1:STN:280:DC%2BD3c7jvV2ntA%3D%3D 10673991 (Pubitemid 29512308)
14. JM Zijlstra EF Comans A van Lingen OS Hoekstra CM Gundy JW Coebergh, et al. 2007 FDG PET in lymphoma: the need for standardization of interpretation. An observer variation study Nucl Med Commun. 28 798 803 10.1097/MNM. 0b013e3282eff2d5 17728610 (Pubitemid 47345712)
15. R Boellaard 2009 Standards for PET image acquisition and quantitative data analysis J Nucl Med. 50 Suppl 1 11S 20 10.2967/jnumed.108.057182 1:CAS:528:DC%2BD1MXmtFahsb8%3D 19380405
16. VJ Lowe DM Delong JM Hoffman RE Coleman 1995 Optimum scanning protocol for FDG-PET evaluation of pulmonary malignancy J Nucl Med. 36 883 887 1:STN:280:DyaK2M3ls12qsg%3D%3D 7738668
17. NE Avril WA Weber 2005 Monitoring response to treatment in patients utilizing PET Radiol Clin North Am. 43 189 204 10.1016/j.rcl.2004.09.006 15693656 (Pubitemid 40326568)
18. E Bastiaannet H Groen PL Jager DCP Cobben WTA van der Graaf W Vaalburg, et al. 2004 The value of FDG-PET in the detection, grading and response to therapy of soft tissue and bone sarcomas; a systematic review and meta-analysis Cancer Treat Rev. 30 83 101 10.1016/j.ctrv.2003.07.004 1:STN:280: DC%2BD2c%2FmsFWquw%3D%3D 14766127 (Pubitemid 38240089)
19. GR Borst JSA Belderbos R Boellaard EFI Comans K de Jaeger AA Lammertsma, et al. 2005 Standardised FDG uptake: a prognostic factor for inoperable non-small cell lung cancer Eur J Cancer. 41 1533 1541 10.1016/j.ejca.2005.03.026 15953716 (Pubitemid 40981834)
20. YE Erdi 2007 The use of PET for radiotherapy Curr Med Imaging Rev. 3 3 16 10.2174/157340507779940291
21. LF Geus-Oei HF van der Heijden FH Corstens WJ Oyen 2007 Predictive and prognostic value of FDG-PET in nonsmall-cell lung cancer: a systematic review Cancer. 110 1654 1664 10.1002/cncr.22979 17879371 (Pubitemid 47557290)
22. CJ Hoekstra SG Stroobants EF Smit J Vansteenkiste H van Tinteren PE Postmus, et al. 2005 Prognostic relevance of response evaluation using [F-18]-2-fluoro-2-deoxy-D-glucose positron emission tomography in patients with locally advanced non-small-cell lung cancer J Clin Oncol. 23 8362 8370 10.1200/JCO.2005.01.1189 16293866 (Pubitemid 46264010)
23. SM Larson LH Schwartz 2006 18F-FDG PET as a candidate for "qualified biomarker": functional assessment of treatment response in oncology J Nucl Med. 47 901 903 1:CAS:528:DC%2BD28XmtlWmsbk%3D 16741296
24. JF Vansteenkiste SG Stroobants 2001 The role of positron emission tomography with 18F-fluoro-2-deoxy-D-glucose in respiratory oncology Eur Respir J. 17 802 820 10.1183/09031936.01.17408020 1:STN:280:DC%2BD38%2Fht1aktw%3D%3D 11401078 (Pubitemid 32492571)
25. WA Weber 2005 Use of PET for monitoring cancer therapy and for predicting outcome J Nucl Med. 46 983 995 1:CAS:528:DC%2BD28XitFSqtrg%3D 15937310
26. G Borst J Belderbos R Boellaard E Comans K de Jaeger A Lammertsma, et al. 2005 Prognostic significance of the 18FDG-PET standardized uptake value for inoperable non-small cell lung cancer patients after high-dose radiotherapy Lung Cancer. 49 S50 10.1016/S0169-5002(05)80279-X
27. KS Dai DY Tai P Ho CC Chen WC Peng ST Chen, et al. 2004 Accuracy of the EasyTouch blood glucose self-monitoring system: a study of 516 cases Clin Chim Acta. 349 135 141 10.1016/j.cccn.2004.06.010 1:CAS:528:DC%2BD2cXotlaitbo%3D 15469866 (Pubitemid 39311998)
28. ICRP 2008 Radiation dose to patients from radiopharmaceuticals. Addendum 3 to ICRP Publication 53. ICRP Publication 106. Approved by the Commission in October 2007 Ann ICRP. 38 1 197 1:STN:280:DC%2BD1M%2Fot1Oiuw%3D%3D 19154964
29. M Lassmann L Biassoni M Monsieurs C Franzius 2008 The new EANM paediatric dosage card: additional notes with respect to F-18 Eur J Nucl Med Mol Imaging 35 1666 1668 10.1007/s00259-008-0799-9 1:STN:280:DC%2BD1crjtVOiug%3D%3D 18574583
30. R Boellaard NC Krak OS Hoekstra AA Lammertsma 2004 Effects of noise, image resolution, and ROI definition on the accuracy of standard uptake values: a simulation study J Nucl Med. 45 1519 1527 15347719
31. Y Masuda C Kondo Y Matsuo M Uetani K Kusakabe 2009 Comparison of imaging protocols for 18F-FDG PET/CT in overweight patients: optimizing scan duration versus administered dose J Nucl Med. 50 844 848 10.2967/jnumed.108.060590 19443586
32. R Boellaard A van Lingen SCM van Balen AA Lammertsma 2004 Optimization of attenuation correction for positron emission tomography studies of thorax and pelvis using count-based transmission scans Phys Med Biol. 49 N31 38 10.1088/0031-9155/49/4/N01 1:STN:280:DC%2BD2c7hsFahtA%3D%3D 15005170 (Pubitemid 38255943)
33. M Westerterp J Pruim W Oyen O Hoekstra A Paans E Visser, et al. 2007 Quantification of FDG PET studies using standardised uptake values in multi-centre trials: effects of image reconstruction, resolution and ROI definition parameters Eur J Nucl Med Mol Imaging 34 392 404 10.1007/s00259-006- 0224-1 17033848 (Pubitemid 46295349)
34. Meignan M, Gallamini A, Haioun C. Report on the first international workshop on interim-PET scan in lymphoma. Leuk Lymphoma. 2009;1-4.
35. NC Krak R Boellaard OS Hoekstra JWR Twisk CJ Hoekstra AA Lammertsma 2005 Effects of ROI definition and reconstruction method on quantitative outcome and applicability in a response monitoring trial Eur J Nucl Med Mol Imaging 32 294 301 10.1007/s00259-004-1566-1 15791438 (Pubitemid 40562120)
36. X Geets JA Lee A Bol M Lonneux V Gregoire 2007 A gradient-based method for segmenting FDG-PET images: methodology and validation Eur J Nucl Med Mol Imaging 34 1427 1438 10.1007/s00259-006-0363-4 17431616 (Pubitemid 47312577)
37. JA van Dalen AL Hoffmann V Dicken WV Vogel B Wiering TJ Ruers, et al. 2007 A novel iterative method for lesion delineation and volumetric quantification with FDG PET Nucl Med Commun. 28 485 493 10.1097/MNM. 0b013e328155d154 17460540 (Pubitemid 46684199)
38. M Hatt F Lamare N Boussion A Turzo C Collet F Salzenstein, et al. 2007 Fuzzy hidden Markov chains segmentation for volume determination and quantitation in PET Phys Med Biol. 52 3467 3491 10.1088/0031-9155/52/12/010 1:STN:280:DC%2BD2svks12qug%3D%3D 17664555 (Pubitemid 46830637)
39. HN Greuter R Boellaard A van Lingen EJ Franssen AA Lammertsma 2003 Measurement of 18F-FDG concentrations in blood samples: comparison of direct calibration and standard solution methods J Nucl Med Technol. 31 206 209 1:CAS:528:DC%2BD2cXhsVOktLc%3D 14657286